15206206

Source:http://linkedlifedata.com/resource/pubmed/id/15206206

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0039286, umls-concept:C0232970, umls-concept:C0246421, umls-concept:C1522673, umls-concept:C1696465, umls-concept:C2603343
pubmed:issue	4
pubmed:dateCreated	2004-6-21
pubmed:language	ita
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101153052
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Aromatase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Estrogens, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Nitriles, http://linkedlifedata.com/resource/pubmed/chemical/Progesterone, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen, http://linkedlifedata.com/resource/pubmed/chemical/Triazoles, http://linkedlifedata.com/resource/pubmed/chemical/letrozole
pubmed:status	MEDLINE
pubmed:author	pubmed-author:AnastasiPaolaP, pubmed-author:GoriStefaniaS, pubmed-author:MarrocoloFrancescaF
pubmed:volume	3
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	S27-31
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15206206-Aged, pubmed-meshheading:15206206-Antineoplastic Agents, Hormonal, pubmed-meshheading:15206206-Aromatase Inhibitors, pubmed-meshheading:15206206-Breast Neoplasms, pubmed-meshheading:15206206-Chemotherapy, Adjuvant, pubmed-meshheading:15206206-Clinical Trials, Phase III as Topic, pubmed-meshheading:15206206-Disease-Free Survival, pubmed-meshheading:15206206-Enzyme Inhibitors, pubmed-meshheading:15206206-Estrogens, pubmed-meshheading:15206206-Female, pubmed-meshheading:15206206-Fractures, Bone, pubmed-meshheading:15206206-Humans, pubmed-meshheading:15206206-Middle Aged, pubmed-meshheading:15206206-Multicenter Studies as Topic, pubmed-meshheading:15206206-Neoplasm Proteins, pubmed-meshheading:15206206-Neoplasms, Hormone-Dependent, pubmed-meshheading:15206206-Nitriles, pubmed-meshheading:15206206-Osteoporosis, Postmenopausal, pubmed-meshheading:15206206-Progesterone, pubmed-meshheading:15206206-Quality of Life, pubmed-meshheading:15206206-Randomized Controlled Trials as Topic, pubmed-meshheading:15206206-Tamoxifen, pubmed-meshheading:15206206-Triazoles
pubmed:articleTitle	[Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer: the MA-17 study].
pubmed:affiliation	SC Oncologia Medica, Azienda Ospedaliera di Perugia.
pubmed:publicationType	Journal Article, Comparative Study